# A Clinical Trial of Freeze-dried Human Rabies Vaccine (Vero Cells)

> **NCT04852068** · PHASE3 · UNKNOWN · sponsor: **Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd.** · enrollment: 2480 (estimated)

## Conditions studied

- Rabies Vaccine Adverse Reaction
- Safety and Efficacy

## Interventions

- **BIOLOGICAL:** Freeze-dried human rabies vaccine (Vero cells) Zhifeilongkoma - 5-dose program
- **BIOLOGICAL:** Freeze-dried human rabies vaccine (Vero cells) Zhifeilongkoma - 4-dose program
- **BIOLOGICAL:** Freeze-dried human rabies vaccine (Vero cells) Chengda - 5-dose program
- **BIOLOGICAL:** Freeze-dried human rabies vaccine (Vero cells) Chengda - 4-dose program

## Key facts

- **NCT ID:** NCT04852068
- **Lead sponsor:** Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-04-10
- **Primary completion:** 2024-09-30
- **Final completion:** 2024-10-30
- **Target enrollment:** 2480 (ESTIMATED)
- **Last updated:** 2023-11-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04852068

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04852068, "A Clinical Trial of Freeze-dried Human Rabies Vaccine (Vero Cells)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04852068. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*